It’s a treatment called immunotherapy, and it removes the obstacles to my own immune system to fight against cancer, basically—it’s kind of complicated. But it’s worked very well for me, and I had an MRI for 2 hours and 10 minutes, and then the doctors determined that I didn’t need any more treatments.
—Former US President Jimmy Carter, announcing to his Sunday school class at Maranatha Baptist Church in Plains, Georgia, that he would stop receiving treatment after three months of immunotherapy aimed at the melanoma that had spread to his brain (March 7)
Commonly discussed causes of irreproducibility, such as poor experimental design and mislabeled reagents, are actually symptoms. The elephant in the room is hyper-competition, which continuously fuels those symptoms. Competition has always been vital to science but hyper-competition ratchets up pressures to a breaking point and changes the landscape.
—Judith Kimble, University of Wisconsin–Madison geneticist, speaking at the 2016 BioPolicy Summit on research reproducibility held earlier this year in Washington, DC (February 9)
The mistake is to think that any published paper or journal article is the end of the story and a statement of incontrovertible truth. It is a progress report.
—Stuart Firestein, former chair of the Department of Biological Sciences at Columbia University, in a Los Angeles Times op-ed about science’s reproducibility crisis (February 14)
In STAP, people got extremely pissed off about the letter P—for pluripotency—while the letter S—for stimulus—was the most interesting.
—Frederic Michon, University of Helsinki developmental biologist, quoted in a New Yorker feature on the discredited stem cell reprogramming protocol (“The Stress Test”) by Dana Goodyear (February 29)
The progress over the past forty-five years in combating cancer arose largely from challenging authority and rejecting conventional thinking. That means skeptics in both science and policy should be eagerly welcomed, not damned.
—Harvard University clinical researcher and New Yorker staff writer Jerome Groopman, in his review of The Death of Cancer by Vincent T. DeVita Jr. and Elizabeth DeVita-Raeburn, The New York Review of Books (March 10)
A great chorus of formal condemnation shall be lifted up, and my male colleagues will sputter with gall, appalled by the actions of bad apples so rare they have been encountered by every single woman I know.
—Plant biologist Hope Jahren, on the appropriate response to the pervasive practice of sexual harassment in academic science, in an opinion piece in The New York Times Sunday Review (March 4)